华恒生物,688639,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2082,1512,570,27.36%,2.69% 其他,1499,1111,388,25.89%,1.83% β-丙氨酸,3456,2150,1306,37.8%,6.16% L-丙氨酸,36213,19873,16340,45.12%,77.03% D-泛酸钙,3908,1886,2023,51.76%,9.54% DL-丙氨酸,1567,981,586,37.38%,2.76% 华恒生物,688639,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),904,665,239,26.41%,2.01% 其他,2059,1327,732,35.57%,6.17% L-丙氨酸,19249,10575,8674,45.06%,73.09% D-泛酸钙,2864,924,1940,67.74%,16.35% DL-丙氨酸,770,488,282,36.64%,2.38% 华恒生物,688639,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3204,2788,416,12.99%,1.84% 其他,3312,1848,1465,44.22%,6.49% L-丙氨酸,34903,18538,16364,46.89%,72.46% D-泛酸钙,4744,1561,3184,67.11%,14.1% DL-丙氨酸,2968,1812,1156,38.94%,5.12% 华恒生物,688639,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2541,2310,232,9.12%,1.39% 其他,677,382,295,43.61%,1.77% L-丙氨酸,35532,20346,15185,42.74%,90.87% DL-丙氨酸,3335,2336,999,29.96%,5.98% 华恒生物,688639,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2823,2746,77,2.72%,0.58% 其他,943,905,38,3.99%,0.28% L-丙氨酸,32242,19531,12711,39.42%,95.83% DL-丙氨酸,2247,1808,438,19.51%,3.31% 华恒生物,688639,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),0,-- ,-- ,--,--% 其他,1166,-- ,-- ,--,--% L丙氨酸,16411,-- ,-- ,--,--% DL丙氨酸,1282,-- ,-- ,--,--% 华恒生物,688639,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3,0,2,87.79%,0.02% 其他,1285,1283,1,0.1%,0.01% DL丙氨酸,2602,1631,971,37.3%,8.22% L丙氨酸,27251,16416,10835,39.76%,91.75% 华恒生物,688639,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 L丙氨酸,11594,7274,4320,37.26%,89.71% DL丙氨酸,1322,821,501,37.89%,10.4% 其他,399,405,-5,-1.32%,-0.11% 华恒生物,688639,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3,5,-2,-82.52%,-0.03% L丙氨酸,22837,15265,7573,33.16%,90.56% DL丙氨酸,2177,1415,762,35.01%,9.12% 其他,329,300,29,8.79%,0.35% 华恒生物,688639,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2,4,-2,-102.68%,-0.04% L丙氨酸,12109,8005,4104,33.89%,91.42% 其他,159,142,17,10.57%,0.38% DL丙氨酸,1069,699,371,34.66%,8.25% 华恒生物,688639,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3,3,0,1.35%,0% 丙氨酸,22400,15053,7347,32.8%,99.86% 其他,84,74,11,12.55%,0.14% 华恒生物,688639,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 DL丙氨酸,1039,858,181,17.4%,6.86% 其他,46,39,7,14.65%,0.25% 其他(补充),12,12,-0,-0.42%,-0% L丙氨酸,10305,7857,2448,23.76%,92.89% 华恒生物,688639,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1,-- ,-- ,--,0% 其他,662,583,79,11.96%,1.97% DL丙氨酸,2548,2045,503,19.75%,12.53% L丙氨酸,14130,10696,3433,24.3%,85.5% 华恒生物,688639,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),16,3,13,83.27%,1.16% 其他,364,297,67,18.48%,6.05% DL丙氨酸,1454,1287,167,11.5%,15.05% L丙氨酸,6835,5971,864,12.63%,77.73%